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the Beck at six months (48% vs. 37%, P  .05). Greater
quantitative reduction in symptom scores on the Hamil-
ton at six months (10.4 vs. 8.1, P  .006) were observed.
Telehealth care improved mental functioning at six weeks
(47.1 vs. 42.6, P  .004) and treatment satisfaction at six
weeks (4.41 vs. 4.17, P  .004) and six months (4.20 vs.
3.94, P  .001). Medication adherence was the same in
all groups and adding peer support to telehealth care did
not improve the main outcomes.
CONCLUSION: Nurse Telehealth Care improves clinical
outcomes of antidepressant treatment, improves patient
satisfaction, and fits well in primary care. The nurse tele-
health care program has been implemented in Maine,
Ohio and Southern California.
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OBJECTIVE: Newer antipsychotics have been associated
with increased weight gain. There is also mounting evi-
dence that this leads to noncompliance and a lower qual-
ity of life. Gaining weight is also undesirable for health
reasons and may lead to increased use of health-care re-
sources. This study considers the association between
weight gain and acute service use for patients with
schizophrenia.
METHODS: Questionnaires were mailed to people with
schizophrenia identified through National Alliance for
the Mentally Ill and the National Mental Health Associa-
tion in spring 2000 (n  390). Data presented here are
from the 345 respondents who reported weight loss (n 
94, 27%), no weight change (n  106, 31%), some
weight gain (1–14lbs; n  70, 20%), and significant
weight gain (15lbs; n  75, 22%) within the last six
months. Acute service use was defined as emergency
room (ER) visit or hospitalization. Cost values were
those reported in Ernst and Hay (1994). For each individ-
ual, total costs were computed by summing across cate-
gories.
RESULTS: The group reporting significant weight gain
was significantly more likely to use acute services than
the other three groups (p  .001 for hospitalization, p 
.005 for ER visit). The association remained significant
when controlling for other variables in multivariate anal-
yses, including age, gender, ethnicity, and overall distress.
Overall costs were highest for those who gained 15 or
more pounds ($9,486). Those who lost weight incurred
costs of $7,400, those who did not change weight in-
curred costs of $4,095, and those who gained 1–14
pounds incurred costs of $3,647.
DISCUSSION: Our preliminary results suggest that re-
cent weight gain is associated with greater use of acute
services and higher costs. There are several plausible ex-
planations. For example, physicians might change medi-
cations for people doing poorly (e.g., start a new medica-
tion after an acute psychiatric episode). Another possibility
is that acute medical services are more likely to be needed
after an episode of rapid weight gain.
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OBJECTIVE: To predict Health State Values (HSV) from
health-related quality of life (HRQL) assessments could,
if possible, be a fruitful way to use HRQL values for
health-economic evaluations. With this in mind, we in-
vestigated to what degree values from the EuroQol in-
strument, the EQ-5D index, and the EQ-VAS visual ana-
log scale, could be predicted using HRQL measures for
patients with respiratory diseases.
METHODS: Data from two surveys of patients with res-
piratory disease were used for this evaluation. The first
data set was from 206 patients in Hungary suffering from
asthma, and the other was from 120 patients in the
northern part of Sweden with COPD. Both surveys in-
cluded patients with different severities of the diseases.
The HRQL instruments used in both surveys were the SF-
36, a generic instrument, and St George’s Respiratory
Questionnaire (SGRQ), a disease-specific instrument. The
two data sets were analyzed separately using a multiple
logistic regression model in a stepwise manner to predict
EQ-5D and EQ-VAS from the eight domains of SF-36 and
the three domains of SGRQ, after transformation of EQ-
5D and EQ-VAS to a 0–1 range.
RESULTS: The amount of variation in both the EQ-5D
and EQ-VAS that could be explained from the combined
HRQL measures was at most 56%. EQ-5D had larger
values than EQ-VAS. Using SF-36 domains only as pre-
dictors gave marginally lower values. The two domains
from SF-36 with best predictability explained about 90%
of the reduction achieved with all 11 domains together
from the two HRQL-measures, indicating correlation be-
tween the different domains.
CONCLUSION: Values for EQ-5D and EQ-VAS pre-
dicted from SF-36 and SGRQ have moderate precision
and should be used cautiously.
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